drugset / Trial / NCT00802672

Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis

NCT00802672

Phase 3 Completed 561 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Cream (Test Product) and Ciclopirox Cream 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and to show the superiority of the active treatments over that of the vehicle.

Timeline

Start
2003-12
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclopirox Olamine Unknown 0.77 % Topical

Indications